|
CHTF8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44389999956474E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.05710000331794E-08 |
| Normal-vs-Stage2 |
1.027570E-01 |
| Normal-vs-Stage3 |
1.184970E-03 |
| Normal-vs-Stage4 |
3.05929948041239E-10 |
| Stage1-vs-Stage2 |
3.365000E-01 |
| Stage1-vs-Stage3 |
5.265400E-01 |
| Stage1-vs-Stage4 |
3.318200E-03 |
| Stage2-vs-Stage3 |
2.414800E-01 |
| Stage2-vs-Stage4 |
1.204360E-02 |
| Stage3-vs-Stage4 |
5.270300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30129999945206E-07 |
| Normal-vs-AfricanAmerican |
2.6679999987067E-08 |
| Normal-vs-Asian |
1.497790E-01 |
| Caucasian-vs-AfricanAmerican |
2.158800E-01 |
| Caucasian-vs-Asian |
7.209400E-01 |
| AfricanAmerican-vs-Asian |
9.793000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.72729999589916E-08 |
| Normal-vs-Female |
5.69080000000222E-05 |
| Male-vs-Female |
9.943200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.95310031773033E-10 |
| Normal-vs-Extreme_Weight |
4.90629999960746E-08 |
| Normal-vs-Obese |
2.37909999999397E-05 |
| Normal-vs-Extreme_Obese |
6.693000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.755360E-01 |
| Normal_Weight-vs-Obese |
2.556400E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.081400E-01 |
| Extreme_Weight-vs-Obese |
3.536600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.048960E-01 |
| Obese-vs-Extreme_Obese |
3.851400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.361700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.78805999999643E-05 |
| Normal-vs-Age(61-80Yrs) |
1.36699999986334E-07 |
| Normal-vs-Age(81-100Yrs) |
2.540800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.148000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.977200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.595570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.583600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.081000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.968600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.79520000000078E-05 |
| Normal-VS-Type2 PRCC |
2.02730000009588E-07 |
| Normal-VS-KIRP CIMP |
6.67859999525788E-08 |
| Normal-VS-Unclassified PRCC |
1.663620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.165500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.552200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.463800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.277200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.729900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.267990E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79169999999984E-05 |
| Normal-vs-N1 |
2.09799999999483E-05 |
| Normal-vs-N2 |
1.98489999991835E-07 |
| N0-vs-N1 |
4.606800E-01 |
| N0-vs-N2 |
2.653200E-01 |
| N1-vs-N2 |
3.309200E-01 |
|
|
